BPT Crunch

Companies on the Cutting Edge of Healthcare Innovations

back to Marketplace

Storm Therapeutics

Storm Therapeutics logo

Founded
2015
Geography
United Kingdom based
Funding
$38 M

STORM Therapeutics is a University of Cambridge spin-out, translating the ground-breaking work of Professors Tony Kouzarides and Eric Miska in RNA epigenetics into the discovery of first-in-class drugs in oncology and other diseases. It is the leading company currently tackling disease through modulating RNA modifying enzymes and is developing a unique platform to address these enzyme classes, including RNA methyltransferases.

Technologies

RNA-focused Startups  


Posts Mentioning This Company

R&D Platform


Pipelines

No pipelines published yet

Products

 

Services

No services posted yet